Print

U.S. Denies Approval of XenoPort, Inc. (XNPT), GlaxoSmithKline (GSK) RLS Drug; Xenoport  
2/18/2010 6:54:03 AM

Bookmark and Share

Reuters -- U.S. regulators have denied approval for a drug from XenoPort (XNPT.O) and GlaxoSmithKline (GSK.L) to treat restless legs syndrome because of a potential link to cancer found in rats.

//-->